WebMar 21, 2024 · All earnings call transcripts on Can-Fite BioPharma Ltd. (CANF) stock. Read or listen to the conference call. Download the investor presentation - earnings call slides. WebApr 10, 2024 · PETACH TIKVA, Israel,, April 10, 2024--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address ...
Can-Fite BioPharma Ltd. Reports Earnings Results for the Full Year ...
WebMar 30, 2024 · Can-Fite Biopharma Ltd ADR (CANF) reported a 4th Quarter December 2024 loss of $1.11 per share on revenue of $0.2 million. The consensus estimate was a loss of $0.57 per share on revenue of $0.3 million. Revenue fell 3.4% compared to the same quarter a year ago. WebApr 10, 2024 · RTTNews. Apr. 10, 2024, 07:34 AM. (RTTNews) - Can-Fite BioPharma Ltd. (CANF) announced it received a positive opinion from the Committee for Medicinal Products for Human Use of the European ... show me fiber
Can-Fite BioPharma Ltd. (CANF) Earnings Transcripts
WebJan 17, 2024 · Meanwhile, the Medical sector has returned an average of -12.7% on a year-to-date basis. This means that CanFite Biopharma Ltd is performing better than its sector in terms of year-to-date returns. Cellectar Biosciences, Inc. (CLRB) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the ... WebThe Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ... WebDec 31, 2024 · Can-Fite BioPharma Ltd. meldete die Ergebnisse für das am 31. Dezember 2024 endende Geschäftsjahr. Für das Gesamtjahr meldete das Unternehmen einen Umsatz von 0,81 Mio. USD, verglichen mit 0,853 Mio.... 11 April 2024 show me ferret